Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Daily intake of short-chain fatty acids and its effects on metabolic health

Official title: The Impact of 12 Weeks Intervention With Plant-based Oat Drink Rich in Short-chain Fatty Acids on Postprandial Lipidemia in Individuals at Risk for Metabolic Syndrome

Run by KU Leuven · NCT06951386 · Data updated 2026-11-12

This study is testing whether drinking a daily beverage with short-chain fatty acids can help people at risk for metabolic syndrome improve their heart and metabolic health over 12 weeks.

More Blood Pressure trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorKU Leuven
Academic / other
Locations1 site (Leuven, Vlaams-Brabant)
StatusRecruiting
StartedFebruary 11, 2025
Main results expectedFebruary 28, 2026
Study endsFebruary 28, 2026
Registry record updatedMay 4, 2025
Trial IDNCT06951386 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with central obesity and at least one additional risk factor for metabolic syndrome.

Probably not a fit

Patients with gastrointestinal disorders or those on specific diets such as weight loss or vegan may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of a daily drink enriched with short-chain fatty acids (SCFAs) on cardiometabolic health in individuals at risk for metabolic syndrome over a 12-week period. Participants will be randomly assigned to consume either the SCFA-enriched drink or a control oat drink. Key metabolic parameters such as blood pressure, body weight, waist and hip circumference, body composition, energy expenditure, glucose, insulin, and blood lipids will be measured before and after the intervention. The study aims to determine if daily SCFA intake can improve these health markers.

Why it matters

Potential benefit: If successful, this study could lead to dietary recommendations that improve cardiometabolic health and reduce the risk of metabolic syndrome.

How similar studies have gone: Other studies have shown promising results with dietary interventions involving short-chain fatty acids, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* male and female participants
* central obesity ( BMI ≥ 25 kg/m² or waist circumference ≥ 80 cm for women/ ≥ 94 cm for men)
* One additional risk factor for metabolic syndrome:

  1. Insulin resistance (HOMA-IR ≥ 1.7 or fasting glucose ≥ 100 mg/dl)
  2. Triglyceride concentration ≥ 150 mg/dl
  3. HDL-cholesterol \< 40 mg/dl for women/ \< 50 mg/dl for men
  4. Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg
* knowledge of English

Exclusion Criteria:

* gastrointestinal disorders such as IBD, IBS, celiac disease, chronic constipation, chronic diarrhoea
* history of abdominal surgery, except for appendectomy
* Use of antihypertensive, cholesterol lowering, glucose-regulating drugs and corticosteroids
* Use of antibiotics 3 months prior to the start or during the study
* Use of probiotics and prebiotics 2 weeks prior to the start of the study/ during the study
* Being on weight loss, gluten-free, lactose-free or vegan diet
* Pregnancy, lactation or wish to become pregnant
* Previous or current substance/ alcohol dependence or abuse
* Hyper- or hypothyroidism
* Allergy or intolerance to oat milk

Where it's running

  • KU Leuven/ UZ Leuven
    Leuven, Vlaams-Brabant, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.